Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism

Published:2016-08 Issue: Volume:459 Page:25-29
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Duan Linli,Zhang Nuofu,Yan Huang,Guo Yehui,Hong Cheng,Yang Xinyan,Su Xiaofen,Chen Rongchang,Zhou Ying,Zhong Nanshan,Liu Chunli

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference25 articles.

1. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism;Carrier;Ann. Intern. Med.,2010

2. The epidemiology of venous thromboembolism;White;Circulation,2003

3. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort;Tagalakis;Am. J. Med.,2013

4. Pulmonary embolism and deep vein thrombosis;Goldhaber;Lancet,2012

5. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study;Silverstein;Arch. Intern. Med.,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey;Thrombosis Research;2021-05

2. Efficacy of rivaroxaban for the treatment of Chinese patients with acute pulmonary embolism;Medicine;2021-04-02

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP